Jefferies Financial Group cut shares of Tivity Health (NASDAQ:TVTY) from a buy rating to a hold rating in a report published on Thursday, BenzingaRatingsTable reports. The brokerage currently has $16.00 price objective on the stock. Jefferies Financial Group also issued estimates for Tivity Health’s Q1 2020 earnings at $0.11 EPS, Q2 2020 earnings at $0.80 EPS, Q3 2020 earnings at $0.58 EPS, Q4 2020 earnings at $0.71 EPS, FY2020 earnings at $2.21 EPS and FY2021 earnings at $2.71 EPS.
TVTY has been the subject of a number of other research reports. Cantor Fitzgerald lowered Tivity Health from an overweight rating to a neutral rating and lowered their price target for the company from $40.00 to $17.00 in a research report on Thursday. Oppenheimer began coverage on Tivity Health in a research report on Friday, February 14th. They set a buy rating and a $32.00 price target for the company. BidaskClub lowered Tivity Health from a buy rating to a hold rating in a research report on Tuesday, February 4th. Piper Sandler lowered Tivity Health from an overweight rating to a neutral rating and set a $25.00 price target for the company. in a research report on Monday, January 27th. Finally, Barrington Research reaffirmed a buy rating and set a $38.00 price target on shares of Tivity Health in a research report on Monday, December 23rd. Ten investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Tivity Health has a consensus rating of Hold and a consensus price target of $21.18.
TVTY traded down $0.50 during midday trading on Thursday, reaching $12.00. 6,566,880 shares of the company’s stock traded hands, compared to its average volume of 1,273,134. The firm has a fifty day moving average of $22.75 and a two-hundred day moving average of $19.48. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of -2.02, a P/E/G ratio of 1.04 and a beta of 1.19. The company has a debt-to-equity ratio of 1.96, a current ratio of 0.94 and a quick ratio of 0.78. Tivity Health has a 52 week low of $11.68 and a 52 week high of $26.07.
Several large investors have recently made changes to their positions in the company. Geode Capital Management LLC raised its position in shares of Tivity Health by 2.8% in the 4th quarter. Geode Capital Management LLC now owns 609,012 shares of the company’s stock worth $12,390,000 after acquiring an additional 16,703 shares in the last quarter. Algert Global LLC bought a new position in shares of Tivity Health in the 4th quarter worth approximately $351,000. Alliancebernstein L.P. raised its position in shares of Tivity Health by 196.6% in the 4th quarter. Alliancebernstein L.P. now owns 222,725 shares of the company’s stock worth $4,531,000 after acquiring an additional 147,630 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Tivity Health in the 4th quarter worth approximately $98,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of Tivity Health by 123.4% in the 4th quarter. Cubist Systematic Strategies LLC now owns 55,412 shares of the company’s stock worth $1,127,000 after acquiring an additional 30,612 shares in the last quarter.
About Tivity Health
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Further Reading: Dividend Reinvestment Plan (DRIP)
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.